Skip to main content

Table 2 Electrochemotherapy parameters

From: Basal cell carcinoma: 10-year experience with electrochemotherapy

Characteristics

No (%)

No of ECT cycles

 1

60 (71.4)

 2a

23 (27.4)

 4

1 (1.2)

Anesthesia

 Local

31 (36.9)

 Sedation

11 (13.1)

 Local + sedation

40 (47.6)

 General

2 (2.4)

Route of BLM administration

 Intratumoral

51 (60.7)

 Intravenous

33 (39.3)

Electrodeb

 Finger

12 (14.2)

 Linear

46 (54.8)

 Hexagonal

26 (31)

Further treatmentsc

 Yesc

18 (21.4)

 No

66 (78.6)

  1. ECT electrochemotherapy, BLM bleomycin
  2. aThe second ECT cycle was administered after a median interval of 3 months (range 2–22)
  3. bSee Fig. 2 for electrode characteristics
  4. cFurther treatments (administered at least 2 months after ECT) included the following: radiotherapy (n = 9 patients), surgery (n = 4 patients), imiquimod (n = 3 patients), vismodegib (n = 3 patients), local 5-FU (n = 2 patients), cryotherapy (n = 1 patient), laser (n = 1 patient), chemotherapy (n = 1 patient)